NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and improved time in range at 13 weeks, researchers reported at the American Diabetes Association Scientific Sessions. As Healio previously reported, the system (twiist, Sequel) received FDA clearance in 2024 for treatment of patients with type 1 diabetes aged 6

NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a currently available system, according to data presented…

NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and improved time in range at 13 weeks, researchers…

NEW ORLEANS —Use of automated insulin delivery during hospitalization may improve glycemic outcomes for adults with insulin-treated diabetes, according to data presented at the…